Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
General Dermatology
•
Pediatric Dermatology
In the era of targeted therapies, are there any specific cytokines that help guide therapy?
Related Questions
Would you recommend continuing Accutane in a teenage female who has experienced a drop in calcium to 8.8 and reductions in albumin and protein levels one month into therapy?
What orals or biologics do you reach for in a child with recalcitrant inverse psoriasis in the groin who has tried and failed topical including steroids, pimecrolimus, zoryve, ketoconazole, and tacrolimus?
What role does oral roflumilast play in dermatology?
Do you incorporate laser hair removal into your treatment plan for patients with HS?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
What are some practical tips for caring for resource-limited patients with severe, Hurley Stage III hidradenitis suppurativa?
How would you manage a patient with profound hyperpigmentation of the face and neck which is attributed to a post-COVID vaccine reaction?
What is your treatment approach to non-uremic calciphylaxis? Which treatment modalities do you combine?
Do you pursue a cardiac evaluation in all patients with an excised cutaneous myxoma?
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?
